SCHEMBL2471585

SCHEMBL2471585

CCCCCc1ccc(CNC(=O)c2ccc(-c3nc(CCl)cs3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.53
TP53 P04637 3/20 0.53
TRPV1 Q8NER1 1/20 0.52
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
POLB P06746 2/20 0.50
GAA P10253 1/20 0.50
PPARA Q07869 2/20 0.47
LMNA P02545 1/20 0.45
RHOC P08134 1/20 0.45
RHOA P61586 1/20 0.45
KLKB1 P03952 2/20 0.45
GFER P55789 1/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
AGTR1 P30556 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6031779 0.86 TP53 (0.50) MAPTTP53TRPV1NPC1RAB9A
SCHEMBL6031787 0.86 TP53 (0.50) MAPTTP53TRPV1PPARALMNA
SCHEMBL12531837 0.84 RAB9A (0.68) MAPTTP53NPC1RAB9APOLB
SCHEMBL5094343 0.81 MAPT (0.56) MAPTTP53TRPV1POLBPPARA
SCHEMBL14208442 0.80 MAPT (0.57) MAPTTP53TRPV1POLBPPARA
SCHEMBL2466239 0.80 MAPT (0.50) MAPTTP53TRPV1PPARALMNA
SCHEMBL4197091 0.75 TRPV1 (0.66) MAPTTRPV1NPC1RAB9AALDH1A1
SCHEMBL6022076 0.75 TRPV1 (0.59) MAPTTRPV1ALDH1A1
SCHEMBL15921857 0.74 TRPV1 (0.71) TRPV1LMNASMN1; SMN2ALDH1A1HTT
SCHEMBL1177024 0.72 KDM4E (0.62) MAPTTP53NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656139-B1 ARYL DICARBOXAMIDES MERCK SERONO SA (CH) 2011-10-05 EP disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-20060189583-A1 Aryl dicarboxamides MERCK SERONO SA (CH) 2006-08-24 US disclosed
EP-1656139-A1 ARYL DICARBOXAMIDES Applied Research Systems ARS Holding N.V. (AN) 2006-05-17 EP disclosed
WO-2005011685-A1 ARYL DICARBOXAMIDES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189583-A1 Aryl dicarboxamides GPR119, PTPRS, ECHS1 MAPT 4883/4885TP53 1795/4885TRPV1 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.